INFANTS Act of 2025

The INFANTS Act of 2025 (HR2472) was introduced in the House on March 27, 2025, and subsequently referred to the House Committee on Energy and Commerce. This bill mandates quarterly testing for contaminants, including lead, cadmium, mercury, and arsenic, in infant and toddler food. It also requires facilities to develop written sampling plans and deems food adulterated if facilities fail to comply, prohibiting its introduction into interstate commerce. This legislation is currently in its early stages, with no further committee actions reported since its referral. This bill does not authorize or appropriate specific funding amounts. Instead, it imposes new regulatory requirements on manufacturers, shifting the financial burden of compliance and testing directly to the companies. The mechanism is regulatory enforcement by the FDA, which will deem non-compliant products as adulterated, preventing their sale. This represents an unfunded mandate on the industry, increasing operational costs for testing, compliance, and potential product recalls. Companies that manufacture infant and toddler food, such as The Kraft Heinz Company ($KHC), General Mills, Inc. ($GIS), Hormel Foods Corporation ($HRL), and The Campbell's Company ($CPB), are directly impacted. These companies will face increased compliance costs for quarterly testing and the development of sampling plans. The risk of product recalls due to contaminant detection also increases, potentially leading to significant financial losses and reputational damage. The bill's definition of "infant and toddler food" is broad, covering food for children up to 24 months, including infant formula. Recent market data shows varied performance among these companies. $KHC has seen a 7-day increase of +3.96% to $23.38, but a 30-day decline of -4.73%. In contrast, $GIS is at $37.52 with a 7-day increase of +0.81% but a 30-day decline of -15.29%. $HRL is at $21.66, experiencing a 7-day decline of -4.37% and a 30-day decline of -11.3%. $CPB is at $21.25, with a 7-day decline of -4.58% and a 30-day decline of -17.64%. These declines for $GIS, $HRL, and $CPB over the past 30 days suggest broader market pressures on consumer staples, which could be exacerbated by the potential for increased regulatory costs from HR2472. The bill's legislative path involves committee review by the House Committee on Energy and Commerce, followed by potential floor votes in the House and Senate, and ultimately presidential assent. Legislative momentum is moderate, with three cosponsors including a senior member, Mr. Pallone, who is a former Chair of the Energy and Commerce Committee. This indicates some bipartisan support and potential for the bill to advance through committee. However, as an early-stage bill, it faces a lengthy process before becoming law.